Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study.
暂无分享，去创建一个
Danielle M. Enserro | J. Blay | K. Robison | C. Fisher | P. Thaker | J. Lea | D. Miller | K. Moxley | P. Ottevanger | M. Hensley | A. Krarup-Hansen | S. Lele | D. O’Malley | H. Hatcher | O. Zivanovic | K. Tewari | D. Miller